Eledon Pharmaceuticals (ELDN) Share-based Compensation (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Share-based Compensation of $2.2 million for Q1 2026, down 23.11% year-on-year from $2.9 million in Q1 2025, and down 10.67% on a QoQ basis from $2.5 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Share-based Compensation data on file, last reported at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 23.11% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 31.51% YoY), and the FY2025 full-year result was $10.5 million, down 20.36% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.2 million, down from $2.5 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $6.6 million in Q4 2024 and bottomed at $1.4 million in Q1 2023.
- The 5-year median for Share-based Compensation is $2.2 million (2022), against an average of $2.4 million.
- The widest annual swing landed in 2024, when Share-based Compensation soared 284.91%; it then slumped 62.55% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $1.5 million in 2022, then climbed by 16.01% to $1.7 million in 2023, then jumped by 284.91% to $6.6 million in 2024, then plunged by 62.55% to $2.5 million in 2025, then dropped by 10.67% to $2.2 million in 2026.
- The last three Share-based Compensation figures came in at $2.2 million (Q1 2026), $2.5 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Dec 31, 2025 | 2.47 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 2.69 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 6.58 Mn |
| Dec 31, 2024 | 6.58 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.73 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 2.31 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Mar 31, 2022 | 2.19 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Dec 31, 2021 | 2.05 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 2.03 Mn |
| Jun 30, 2021 | 2.03 Mn |
| Mar 31, 2021 | 1.77 Mn |
| Mar 31, 2021 | 1.77 Mn |
| Dec 31, 2020 | 1.66 Mn |
| Dec 31, 2020 | 1.66 Mn |
| Sep 30, 2020 | 878,000.00 |
| Sep 30, 2020 | 878,000.00 |
| Jun 30, 2020 | 197,000.00 |
| Jun 30, 2020 | 197,000.00 |
| Mar 31, 2020 | 437,000.00 |
| Mar 31, 2020 | 437,000.00 |
| Dec 31, 2019 | 243,000.00 |
| Dec 31, 2019 | 243,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Jun 30, 2019 | 627,000.00 |
| Jun 30, 2019 | 627,000.00 |
| Mar 31, 2019 | 211,000.00 |
| Mar 31, 2019 | 211,000.00 |
| Dec 31, 2018 | 740,000.00 |
| Dec 31, 2018 | 740,000.00 |
| Sep 30, 2018 | 237,000.00 |
| Sep 30, 2018 | 237,000.00 |
| Jun 30, 2018 | 404,000.00 |
| Jun 30, 2018 | 404,000.00 |
| Mar 31, 2018 | 161,000.00 |
| Mar 31, 2018 | 161,000.00 |
| Dec 31, 2017 | 193,000.00 |
| Dec 31, 2017 | 193,000.00 |
| Sep 30, 2017 | 150,000.00 |
| Sep 30, 2017 | 150,000.00 |
| Jun 30, 2017 | 130,000.00 |
| Jun 30, 2017 | 130,000.00 |
| Mar 31, 2017 | 106,000.00 |
| Mar 31, 2017 | 106,000.00 |
| Dec 31, 2016 | 29,000.00 |
| Dec 31, 2016 | 29,000.00 |
| Sep 30, 2016 | 646,000.00 |
| Sep 30, 2016 | 646,000.00 |
| Jun 30, 2016 | 992,000.00 |
| Jun 30, 2016 | 992,000.00 |
| Mar 31, 2016 | 1.02 Mn |
| Mar 31, 2016 | 1.02 Mn |
| Dec 31, 2015 | 857,000.00 |
| Dec 31, 2015 | 857,000.00 |
| Sep 30, 2015 | 804,000.00 |
| Sep 30, 2015 | 804,000.00 |
| Jun 30, 2015 | 606,000.00 |
| Jun 30, 2015 | 606,000.00 |
| Mar 31, 2015 | 634,000.00 |
| Mar 31, 2015 | 634,000.00 |
| Dec 31, 2014 | 589,000.00 |
| Dec 31, 2014 | 589,000.00 |
| Sep 30, 2014 | 1.18 Mn |
| Sep 30, 2014 | 1.18 Mn |
| Jun 30, 2014 | 250,000.00 |
| Jun 30, 2014 | 250,000.00 |
| Mar 31, 2014 | 90,000.00 |
| Mar 31, 2014 | 90,000.00 |
| Dec 31, 2013 | 101,000.00 |
| Dec 31, 2013 | 101,000.00 |
| Sep 30, 2013 | 47,000.00 |
| Sep 30, 2013 | 47,000.00 |